The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration.
The Italian government has controversially reclassified cannabidiol (CBD) as a narcotic. This latest development is another twist in the ongoing regulatory saga around the hemp-derived compound in the European country.
Referred to as the ‘green wave’ - the cannabis sector is undeniably on the rise across Europe, with policy changes in both medicinal and recreational contexts. BSDA predicts that global cannabis sales will increase by 22 percent in 2022, surpassing $61 billion by 2026. With this in mind, cannabis legalisation both recreational and medical could Referred to as the ‘green wave’ - the cannabis sector is undeniably on the rise across Europe, with policy changes in both medicinal and recreational contexts. BSDA predicts that global cannabis sales will increase by 22 percent in 2022, surpassing $61 billion by 2026. With this in mind, cannabis legalisation both recreational and medical could – Medical cannabis across Europe - where are we now?